References

1. Harrison’s. Text book of Medicine. 17th edition.
2. Gagg SJ, Drysdale J, Worwood M; Human Genet, 1985;71:108-12.
3. Yamada H, Gabuzda TG; J. Lab Clin.Med; 1974;83:477-88.
4. Kirk RL, Ranford IR. et al. HLA complement, C2C4properdin factor B and Glyoxalase type in South Indians, Diabetes Res. Clinic Pract 1985; 1:41-7.
5. NDDG group. Classification and diagnosis of Diabetes Mellitus and other categories of glucose intolerance. Diabetes 1972; 28: 1039-57.
6. Omar Mark. Diabetes 1988; 37: 796-9.
7. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetic Care 1998; 21 (Suppl 1):5-19.
8. Scheele KW. Examen Chemicum Calculi Urinarii, Opuscula 11, p, 73, 1776. Cited from Levene, P.A and Bass, L.W: Nucleic Acids. New York, Chemical catalogcompany, 1931.
9. Wollaston, W.H. On Gouty and urinary concretions, Phil. Trans. London, 1797,87:386.
10. Becker, Michael A, M.D., Schumaker, H. Ralph Jr., M.D., Wortmann, Robert L. M.D., and others; Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout. New England Journal of Medicine 2005; 353: 2450-61
11. Note on the estimation of uric acid by the Hopkins-folin method. By Robert Campbell Garry. Institute of Physiology, Glasgow University.
12. Sir Archibald Garrod and Alkaptonuria –‘story of metabolic genetics’ C Prasad1,*,   PA Galbraith2
13. Alkylation of oxypurines by α,ω-dihaloalkanes 1. Reaction of xanthine sodium salts and some N-methyl derivatives with α,ω-dihaloalkanesI. Sh. Salikhov, V. O. Kuznetsov and V. S. Reznik
14. Urate Kinetics in Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency: Their Significance for the Understanding of GoutB. T. EMMERSON, R. B. GORDON and L. A. JOHNSONQJM: An International Journal of MedicineVolume45, Issue1Pp. 49-61.

Corresponding Author

Dr M.F.Mohamed Azath Ali

M.D Gen Medicine Consultant Physician K.G Multispeciality Hospital, Thanjavur, India